Does dapagliflozin affect the metabolic response in patients with elevated alanine aminotransferase and Type 2 diabetes? The Association of British Clinical Diabetologists (ABCD) nationwide dapagliflozin audit

被引:0
|
作者
Yadagiri, M. [1 ]
Sen Gupta, P. [1 ]
Stephens, J. W. [2 ]
Robinson, A. [3 ]
Phylactou, M. [4 ]
Kennedy, A. [5 ]
Clark, J. [6 ]
Wilding, J. [7 ]
Adamson, K. A. [8 ]
Ryder, R. E. J. [1 ]
机构
[1] Sandwell & West Birmingham Hosp NHS Trust, Dept Diabet, Birmingham, W Midlands, England
[2] Abertawe Bro Morgannwg Univ NHS Trust, Dept Diabet, Swansea, W Glam, Wales
[3] Royal United Hosp Bath NHS Trust, Dept Diabet, Bath, Avon, England
[4] Queen Elizabeth II Hosp, Dept Diabet, Welwyn Garden City, Herts, England
[5] Northern Trust, Antrim Area Hosp, Dept Diabet, Coleraine, Antrim, North Ireland
[6] Surrey & Sussex Healthcare NHS Trust, Dept Diabet, Redhill, Surrey, England
[7] Aintree Univ Hosp NHS Fdn Trust, Dept Diabet, Liverpool, Merseyside, England
[8] West Lothian NHS Trust, Dept Diabet, Livingston, Scotland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A73
引用
收藏
页码:30 / 31
页数:3
相关论文
共 41 条
  • [41] Response: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21)
    Hong, Ju-Young
    Park, Keun-Young
    Kim, Jong-Dai
    Hwang, Won-Min
    Lim, Dong-Mee
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2021, 30 (01) : 74 - 75